Empowered Funds’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Sell
2,372
-36,715
-94% -$5.45M ﹤0.01% 1713
2026
Q1
$3.64M Buy
+39,087
New +$3.46M 0.02% 778
2025
Q4
Sell
-4,820
Closed -$471K 1003
2025
Q3
$471K Buy
4,820
+1,106
+30% +$89.1K ﹤0.01% 1427
2025
Q2
$259K Buy
+3,714
New +$212K ﹤0.01% 1563
2025
Q1
Sell
-6,655
Closed -$465K 1617
2024
Q4
$465K Buy
+6,655
New +$553K 0.01% 1210
2024
Q1
Sell
-1,777
Closed -$230K 1373
2023
Q4
$230K Sell
1,777
-18,693
-91% -$2.58M 0.01% 1180
2023
Q3
$3.34M Buy
20,470
+19,061
+1,353% +$3.35M 0.1% 276
2023
Q2
$258K Buy
+1,409
New +$203K 0.01% 1005

Other funds holding ACLS

Empowered Funds's ACLS Position: Q2 2026 in Review

Empowered Funds reduced its Axcelis (ACLS) stake by 94% in Q2 2026, selling an estimated $5.45M and leaving 2,372 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Empowered Funds first reported a position in ACLS in Q2 2023 and has held it in 8 quarters since. The position peaked at $3.64M in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Empowered Funds held 2,372 shares of Axcelis worth $449K as of Q2 2026.
  • Empowered Funds sold 36,715 Axcelis shares in Q2 2026, an estimated $5.45M.
  • Axcelis made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1713 holding.
  • Empowered Funds first reported a position in Axcelis in Q2 2023 and has held it in 8 quarters since.
  • Empowered Funds's Axcelis position peaked at $3.64M in Q1 2026.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.